Abdulla A. Damluji/X
Nov 18, 2025, 08:52
Aspirin or P2Y12 Monotherapy?
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
Very nice review.”
Stay informed with Hemostasis Today.
-
Jul 7, 2026, 17:49Alan Nurden: Safer Antithrombotic Therapy Through GPVI
-
Jul 7, 2026, 17:29Anticoagulation Reversal in 2026: Are We Winning the Bleeding Battle? – Francisco Chacón-Lozsán
-
Jul 7, 2026, 17:25Jim Hoffman: Targeting NETosis to Restore Immune Homeostasis
-
Jul 7, 2026, 17:14Shabneez Hussain: Blood Transfusion Professionals Connecting at ISBT 2026
-
Jul 7, 2026, 17:04Mariam Swidan: Vitamin B12 Deficiency and the Hidden Risk of Neurological Damage
-
Jul 7, 2026, 16:53Heghine Khachatryan: Breaking Barriers in Bleeding Disorder Care for Women and Girls
-
Jul 7, 2026, 16:39Why Medical Alert Identification Matters in Bleeding Disorders – South African Haemophilia
-
Jul 7, 2026, 16:21Hannah Omunakwe: When Blood Becomes the Limiting Treatment in Sickle Cell Disease
-
Jul 7, 2026, 15:54Barbara Lovrencic: Giving the ITP Patient Voice a Stronger Evidence Base